Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - CALMARE THERAPEUTICS Inc | Financial_Report.xls |
| 10-Q - FORM 10-Q - CALMARE THERAPEUTICS Inc | v377106_10q.htm |
| EX-31.1 - EXHIBIT 31.1 - CALMARE THERAPEUTICS Inc | v377106_ex31-1.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.SC. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Competitive Technologies, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Conrad Mir, chief executive officer of the Company, certifies, pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002, that:
| (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: May 15, 2014 | By: | /s/ Conrad Mir |
|
Conrad Mir President, Chief Executive Officer and interim Chief Financial Officer (Duly Authorized Officer, Principal Executive Officer, and Principal Financial Officer and Principal Accounting Officer) | ||
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.